Ground News

Expand Your Understanding.

FDA image

News about FDA

Stay current with all the latest and breaking news about FDA, compare headlines and perspectives between news sources on stories happening today. In total, 579stories have been published about FDA which Ground News has aggregated in the past 3 months.

Covered Most By

Suggest a source

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top FDA News

US FDA approves expanded use of Moderna's RSV vaccine for at-risk adults

FDA · United States

US FDA approves expanded use of Moderna's RSV vaccine for at-risk adults

72% Center coverage: 18 sources

UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity

Infrastructure · United States

UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity

83% Center coverage: 6 sources

/PRNewswire/ -- UCB, a global biopharmaceutical company focused on improving the lives of people with severe diseases, today announced plans for a significant...See the Story

Company in Brooklyn Recalling Mushrooms that Could Be Contaminated with Listeria

FDA · New Canaan

Company in Brooklyn Recalling Mushrooms that Could Be Contaminated with Listeria

60% Center coverage: 5 sources

Hofood99, a company based in Brooklyn, is recalling 200-gram packages of Enoki mushrooms because they could be contaminated with Listeria.See the Story

Blindspots

COVID Concerns: FDA's New Vaccine Guidelines Raise Questions

Merck's Keytruda Secures FDA Nod For Head And Neck Cancer As First Immunotherapy For Use Around Surgery - Merck & Co (NYSE:MRK)

100% Center coverage: 3 sources

The U.S. Food and Drug Administration (FDA) on Friday approved Merck & Co Inc.’s (NYSE:MRK) Keytruda (pembrolizumab) for adult patients with resectable locally advanced head and neck squamous cell carcinoma (HNSCC) whose tumors express PD-L1 (combined positive score of at least 1), as a single agent as neoadjuvant treatment, continued as adjuvant treatment in combination with radiotherapy (RT) with or without cisplatin and then as a single agent…Cancer · United States See the Story

Next-Generation TKI Approved for Advanced ROS1-Positive Lung Cancer

100% Center coverage: 2 sources

(MedPage Today) -- The FDA approved taletrectinib (Ibtrozi) -- a next-generation oral ROS1 tyrosine kinase inhibitor (TKI) -- for the treatment of adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC)...Pharma · United States See the Story

Rwanda FDA advocates for rational drug use to prevent antimicrobial resistance crisis

In Rwanda, improper medicine use is contributing to treatment failures, adverse effects, and antimicrobial resistance (AMR), a persistent concern for public health. The World Hea...World Health Organization · Rwanda Read Article

Atraverse closes US$29 million to boost commercialisation of Hotwire transseptal access technology - Cardiovascular News

Atraverse Medical has announced the close of US$29.4 million in follow-on financing to accelerate growth, building upon the US$12.5 million in prior seed investment that was previously used to obtain US Food and Drug Administration (FDA) 510(k) clearance and begin early commercialisation of Hotwire—the company’s novel radiofrequency (RF) guidewire for left-heart access. Designed to simplify left-heart access through universal sheath compatibilit…FDA · New York Read Article

Inebilizumab Efficacy and Safety Consistent Across Demographic Subgroups of IgG4-RD

Inebilizumab was approved by the FDA under the name Uplizna as the first and only treatment for adult patients with IgG4-RD in April 2025FDA · United States Read Article

U.S. Food & Drug Administration (FDA) Approves Investigational New Drug (IND) Application for Myrio's Lead Product (PHOX2B PC-CAR T) for the Treatment of Ne

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, June 13, 2025 /PRNewswire/ — On 7 May 2025, the FDA approved an IND application enabling Myrio’s lead product (PHOX2B PC-CAR T) to enter human trials. Myrio, in collaboration the leading children’s hospital in Philadelphia have co-developed a Chimeric Antigen Receptor (…FDA · Melbourne Read Article

New FDA-Approved Allergy Spray Now Allowed In Maryland Schools - The BayNet

Open the article to view the coverage from thebaynet.comFDA · Maryland Read Article

FPSA - Staying Compliant With FSMA

The FDA Food Safety Modernization Act, or FSMA, was signed into law on January 4, 2011, and gave the U.S. Food and Drug Administration (FDA) new authority to regulate the U.S. food supply to better protect public health. Read MoreThe post Staying Compliant With FSMA appeared first on FPSA.FDA · United States Read Article

Breaking News Topics Related to FDA